{"id":"NCT00090766","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients","officialTitle":"Safety and Pharmacokinetics of Valganciclovir Syrup Formulation in Pediatric Solid Organ Transplant Recipients","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2004-05","primaryCompletion":"2005-05","completion":"2005-05","firstPosted":"2004-09-06","resultsPosted":"2016-10-31","lastUpdate":"2016-10-31"},"enrollment":63,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cytomegalovirus Infections"],"interventions":[{"type":"DRUG","name":"valganciclovir [Valcyte]","otherNames":[]}],"arms":[{"label":"Valganciclovir Age Group <= 2 Years","type":"EXPERIMENTAL"},{"label":"Valganciclovir Age Group >2 to <12 Years","type":"EXPERIMENTAL"},{"label":"Valganciclovir Age Group >= 12 Years","type":"EXPERIMENTAL"}],"summary":"This study will assess the safety and pharmacokinetics of Valcyte syrup in pediatric solid organ transplant recipients. The anticipated time on study treatment is 3-12 months and the target sample size is less than 100 individuals.","primaryOutcome":{"measure":"Mean Area Under the Concentration-Time Curve From 0 to 24 Hours of Valganciclovir","timeFrame":"Pre-dose; 1-3, 3-7, 7-12 hours post dose on any day between Day 7 to Day 14; Week 6, Week 10, and Week 14","effectByArm":[{"arm":"Valganciclovir Age Group <= 2 Years","deltaMin":65.2,"sd":16.6},{"arm":"Valganciclovir Age Group >2 to < 12 Years","deltaMin":55,"sd":11.9},{"arm":"Valganciclovir Age Group >= 12 Years","deltaMin":50,"sd":11.6}],"pValues":[]},"eligibility":{"minAge":"3 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":17,"countries":["United States","Australia","Canada","France","Germany","Mexico","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":17},"commonTop":["Diarrhoea","Hypertension","Pyrexia","Vomiting","Upper Respiratory Tract"]}}